RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2
Project

LabQuest moved the infrastructure to the cloud Cloud.ru

Customers: Labquest (LabQuest)

Moscow; Pharmaceuticals, Medicine, Healthcare

Product: Cloud Advanced

Project date: 2025/04  - 2025/10

2025: Moving Infrastructure to the Cloud Cloud.ru

LabQuest-Genetics, the molecular genetic laboratory of the medical company LabQuest, has deployed a data processing infrastructure in the cloud Cloud.ru. This increased the speed of genetic research as part of prenatal diagnosis. This was announced by Cloud.ru on November 11, 2025.

In the summer of 2024, the LabQuest-Genetics laboratory launched the direction of genetic research in preparation for childbirth. It was important for the company to organize an automatically scalable infrastructure for processing large amounts of biomaterial sequencing data for pregnant women and IVF program participants. The information obtained through sequencing allows researchers to identify serious genetic pathologies in the unborn child.

The complexity of the work consisted in sharp bursts of load that occurred when regular loading of test results into special software for their analysis "SecVario Platform" of Russian development. In order to flexibly scale the infrastructure to the current load and ensure high data processing speed, the company decided to migrate to the cloud. The company chose Cloud.ru as a cloud provider, deploying infrastructure in high-performance clusters on Kubernetes. The company also configured data backups in the cloud.

File:Aquote1.png
Thanks to Cloud.ru, the LabQuest-Genetics laboratory continuously processes large amounts of data and quickly detects the risks of chromosomal disorders of the fetus and embryos. Moreover, by automatically scaling resources in the cloud, we managed to significantly reduce infrastructure costs during periods of low load. The demand for genetic tests is growing steadily - in the last six months alone, the volume of orders has doubled. In the future of the next two years, we plan to increase the current indicators at least four times, "said Irina Petrova, executive director of LabQuest-Genetics.
File:Aquote2.png

File:Aquote1.png
In the future, the planiuret laboratory will launch the direction of oncogenetics, which will allow performing a full range of modern molecular genetic research for cancer patients. The company also plans to use the cloud to conduct a new type of tests Cloud.ru. We are glad to help LabQuest in creating an infrastructure that significantly reduces time to market and improve the quality of such important medical services for society, "said Anatoly Bibikov, Director of the Cloud.ru Key Clients Department .
File:Aquote2.png